Abstract
Small interfering RNA (siRNAs), the main effector of RNA interference (RNAi), are now routinely used to assess gene function, both in vitro and in vivo, and many innovative screens have been reported on the use of RNAi to identify potential drug targets. Despite several technical advances, however, there are still many challenges in determining the ideal design of siRNA sequence, the activation of the immune system, off-target effects, and competition with endogenous microRNAs for cellular miRNA-processing machinery. Therefore, the translation of RNAi technology into the clinic depends on resolving these challenges. This chapter summarizes recent progress in siRNA design, sensing by the immune system, and discusses some of the promising approaches that are currently being explored in separating siRNA unwanted effects from gene silencing.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S.E, Mello, C. C. (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806–811.
Jorgensen, R. (1990) Altered gene expression in plants due to trans interactions between homologous genes. Trends Biotechnol 8, 340–344.
Hamilton, A.J, Baucombe, D. C. (1999) A species of small antisense RNA in posttranscriptional gene silencing in plants. Science 286, 950–952.
Sen, G. C. (2001) Viruses and interferons. Annu Rev Microbiol 55, 255–281.
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., Tuschl, T. (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494–498.
Sioud, M. (2004) Therapeutic siRNAs. Trends Pharmacol Sci 25, 22–28.
Hannon, G. J., Rossi, J. J. (2004) Unlocking the potential of the human genome with RNA interference. Nature 431, 371–378.
Liu, J., Carmell, M. A., Rivas, F. V., Marsden, C. G., Thomson, J. M., Song, J. J., Hammond, S. M., Joshua-Tor, L., Hannon, G. J. (2004) Argonaute2 is the catalytic engine of mammalian RNAi. Science 305, 1437–1441.
Song, J. J., Smith, S. K., Hannon, G. J., Joshua-Tor, L. (2004) Crystal structure of Argonaute and its implications for RISC slicer activity. Science 305, 1434–1437.
Matranga, C., Tomari, Y., Shin, C., Bartel, D. P., Zamore, P. D. (2005) Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes. Cell 123, 607–620.
Rand, T. A., Petersen, S., Du, F., Wang, X. (2005) Argonaute2 cleaves the anti-guide strand of siRNA during RISC activation. Cell 123, 621–629.
Ma, J. B., Yuan, Y. R., Meister, G., Pei, Y., Tuschl, T., Partel, D. J. (2005) Structural basis for 5′-end-specific recognition of guide RNA by the A. fulgidus Piwi protein. Nature 434, 666–670.
Lee, Y. S., et al. (2004) Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA silencing pathway. Cell 117, 69–81.
Sioud, M., Sørensen, D. R. (2003) Cationic liposome-mediated delivery of siRNAs in adult mice. Biochem Biophys Res Commun 312, 1220–1225.
Jackson, A. L., Bartz, S. R., Schelter, J., Kobayashi, S. V., Burchard, J., Mao, M., Li, B., Cavet, G., Linsley, P. S. (2003) Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol 21, 635–637.
Semizarov, D., Frost, L., Sarthy, A., Kroeger, P., Halbert, D. N., Fesik, S. W. (2003) Specificity of short interfering RNA determined through gene expression signatures. Proc Natl Acad Sci USA 100, 6347–6352.
Sledz, C. A., Holko, M., de Veer, M. J., Silverman, R. H., Williams, B. R. (2003) Activation of the interferon system by short-interfering RNAs. Nat Cell Biol 5, 834–839.
Holen, T., Amrzguioui, M., Wiiger, M. T., Babaie, E., Prydz, H. (2002) Positional effects of short interfering RNAs targeting the human coagulation tissue factor. Nucleic Acids Res 30, 1757–1766.
Schwarz, D. S, et al. (2003) Asymmetry in the assembly of the RNAi enzyme complex. Cell 115, 199–208.
Khvorova, A., Reynolds, A., Jayasena, S. D. (2003) Functional siRNAs and miRNAs exhibit strand bias. Cell 115, 209–216.
Ui-Tei, K., Naito, Y., Saigo, K. (2007) Guidelines for the selection of effectives short-interferin RNA sequences for functional genomics. Methods Mol Biol 361, 201–216.
Li, S., Peters, G. A., Ding, K., Zhang, X., Qin. J., Sen, G. C. (2006) Molecular basis for PKR activation by PACT or dsRNA. Proc Natl Acad Sci USA 103, 1005–1010.
Kato, H., Takeuchi, O., Sato, S., Yoneyama, M., Yamamoto, M., Matsui, K., Uematsu, S., Jung, A., Kawai, T., Ishii, K. J., Yamaguchi, O., Otsu, K., Tsujimura, T., Koh, C. S., Reis e Sousa, C., Matsuura, Y., Fujita, T., Akira, S. (2006) Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441, 101–105.
Meylan, E., Tschopp, T., Karin, M. (2006) Intracellular pattern recognition receptors in the host response. Nature 442, 39–44.
Takeda, K., Akira, S. (2005) Toll-like receptors in innate immunity. Int Immunol 17, 1–14.
Sioud, M. (2005) Innate sensing of self and non-self RNAs by Toll-like receptors. Trends Mol Med 12, 167–176.
Alexopoulou, L., Holt, A. C., Medzhitov, R., Flavell, R. A. (2001) Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413, 732–738.
Heil, F., Hemmi, H., Hochrein, H., Ampenberger, A., Kirschning, C., Akira, S., Lipford, G., Wagner, H., Bauer, S. (2004) Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303, 1526–1529.
Krieg, A. M. (2002) CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 20, 709–760.
Cao, W., Liu, Y. J. (2007) Innate immune functions of plasmacytoid dendritic cells. Curr Opin Immunol 19, 24–30.
Kariko, K., Bhuyan, P., Capodici, J., Weissman, D. (2004) Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through toll-like receptor 3. J. Immunol 172, 6545–6549.
Sioud, M. (2005) Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization. J Mol Biol 348, 1079–1090.
Hornung, V., Guenthner-Biller, M., Bourquin, C., Ablasser, A., Schlee, M., Uematsu, S., Noronha, a., Manoharan, M., Akira, S., de Fougerolles, A., Endres, S., Hartmann, G. (2005) Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat Med 11, 263–270.
Judge, A. D., Sood, V., Shaw, J. R., Fang, D., McClintock, K., MacLachlan, I. (2005) Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat Biotechnol 23, 457–462.
Sioud, M. (2006) Single-stranded small interfering RNA are more immunostimulatory than their double-stranded counterparts: a central role for 2′-hydroxyl uridines in immune responses. Eur J Immunol 36, 1222–1230.
Cekaite, L., Furset, G., Hovig, E., Sioud, M. (2007) Gene expression analysis in blood cells in response to unmodified and 2′-modified siRNAs reveals TLR-dependent and independent effects. J Mol Biol 365, 90–108.
Goodchild, A., Nopper, N., King, A., Doan, T., Tanudji, M., Arndt, G. M., Poidinger, M., Rivory, L. P., Passioura, T. (2009) Sequence determinants of innate immune activation by short interfering RNAs. BMC Immunol 10, 40–48.
Marques, J. T., Devosse, T., Wang, D., Zamanian-Daryoush, M., Serbinowski, P., Hartmann, R., Fujita, T., Behlke, M. A., Williams, B. R. (2006) A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells. Nat Biotechnol 24, 559–565.
Bartel, D. P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281–294.
Han, J., Lee, Y., Yeom, K. H., Nam, J. W., Heo, I., Rhee, J. K., Sohn, S. Y., Cho, Y., Zhang, B. T., Kim, V. N. (2006) Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell 125, 887–901.
Furset, G., Sioud, M. (2007) Design of bifunctional siRNAs: combining immunostimulation and gene-silencing in one single siRNA molecule. Biochem Biophys Res Commun 352, 642–649.
Hornung, V., Ellegast, J., Kim, S., Brzozka, K., Jung, A., Kato, H., Poeck, H., Akira, S., Conzelmann, K. K., Schlee, M., Endres. S., Hartmann, G. (2006) 5′-Triphosphate RNA is the ligand for RIG-I. Science 314, 994–997.
Morrissey, D. V., Lockridge, J. A., Shaw, L., Blanchard, K., Jensen, K., Breen, W., Hartsough, K., Machemer, L., Radka, S., Jadhav, V., Vaish, N., Zinnen, S., Vargeese, C., Bowman, K., Shaffer, C. S., Jeffs, L. B., Judge, A., MacLachlan, I., Polisky, B. (2005) Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat Biotechnol 23, 1002–1007.
Judge, A. D., Bola, G., Lee, A. C., MacLachlan, I. (2006) Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo. Mol Ther 13, 494–505.
Kariko, K., Buckstein, M., Ni, H., Weissman, D. (2005) Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23, 165–175.
Sioud, M. (2007) RNA interference and innate immunity. Adv Drug Deliv Rev 59, 153–163.
Sioud, M., Furset, G., Cekaite, L. (2007) Suppression of immunostimulatory siRNA-driven innate immune activation by 2′-modified RNAs. Biochem Biophys Res Commun 361, 122–126.
Furset, G., Floisand, Y., Sioud, M. (2007) Impaired expression of indoleamine 2, 3-dioxygenase in monocyte-derived dendritic cells in response to Toll-like receptor-7/8 ligands. Immunology 123, 263–271.
Robbins, M., Judge, A., Liang, L., McClintock, K., Yaworski, E., MacLachlan, I. (2007) 2′-O-methyl-modified RNAs act as TLR7 antagonists. Mol Ther 15, 1663–1669.
Zhu, F. G., Reich, C. F., Pisetsky, D. S. (2002) Inhibition of murine dendritic cell activation by synthetic phosphorothioate oligodeoxynucleotides. J Leukoc Biol 72, 1154–1163.
Jackson, A. L., Burchard, J., Leake, D., Reynolds, A., Schelter, J., Guo, J., Johnson, J. M., Lim, L., Karpilow, J., Nichols, K., Marshall, W., Khvorova, A., Linsley, P. S. (2006) Position-specific chemical modification of siRNAs reduces “off-target” transcript silencing. RNA 12, 1197–1205.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Sioud, M. (2011). Promises and Challenges in Developing RNAi as a Research Tool and Therapy. In: Nielsen, H. (eds) RNA. Methods in Molecular Biology, vol 703. Humana Press. https://doi.org/10.1007/978-1-59745-248-9_12
Download citation
DOI: https://doi.org/10.1007/978-1-59745-248-9_12
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-58829-913-0
Online ISBN: 978-1-59745-248-9
eBook Packages: Springer Protocols